Literature DB >> 32418306

Comment on Matricardi PM et al.

Antonio Mirijello1, Maria Maddalena D'Errico1, Antonella La Marca1, Pamela Piscitelli1, Salvatore De Cosmo1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32418306      PMCID: PMC7276801          DOI: 10.1111/pai.13277

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   5.464


× No keyword cloud information.
We read with great interest the review article by Matricardi and colleagues depicting mechanisms of disease for COVID‐19 and analyzing both viral and host factors influencing its course. We particularly agree with authors on the pivotal role of innate immunity in the very early phase of disease, being crucial for the subsequent evolution. Most known weapons of innate immune system are represented by natural antibodies, non‐specific antimicrobial proteins, interferons, cytokines, and cellular elements (ie, natural killer cells). However, innate immunity could be influenced by other, still underrecognized, factors. At present, a solid proof of evidence is available on the ability of vitamin D in modulating immune response. Most of the data are available from the field of bacterial infections and sepsis, being low vitamin D levels associated with a higher risk of infection and mortality. In addition, vitamin D could play a role against viruses by maintaining physical barriers (ie, tight junctions and gap junction), enhancing natural immunity (ie, production of cathelicidin and defensins), and modulating adaptive immune response (ie, modulation of TH1/TH2 response and inflammation). On this connection, emerging data support the role of vitamin D supplementation in reducing the risk and severity of influenza. Both influenza and COVID‐19 show their maximum spread in winter season and the highest severity in elderly people. Reduced vitamin D levels could represent a possible pathophysiological explanation, among others, in both cases. , With this regard, it has been hypothesized that variations in vitamin D status across countries and latitudes could, at least in part, explain variations of mortality from COVID‐19. , However, at present the exact vitamin D status among COVID‐19 patients is unknown. Moreover, the role and mechanisms of vitamin D in the treatment of COVID‐19 are still unexplored and several interventional trials are ongoing. Should these hypotheses be confirmed, universal vitamin D supplementation would represent a possible and inexpensive strategy to enhance natural immunity against COVID‐19.

AUTHOR CONTRIBUTION

Antonio Mirijello: Conceptualization (lead); Methodology (lead). Maria Maddalena D'Errico: Conceptualization (equal). Antonella La Marca: Conceptualization (supporting); Data curation (supporting). Pamela Piscitelli: Conceptualization (equal); Methodology (equal); Project administration (equal). Salvatore De Cosmo: Conceptualization (lead); Data curation (equal); Methodology (equal).
  7 in total

1.  MEDS score and vitamin D status are independent predictors of mortality in a cohort of Internal Medicine patients with microbiological identified sepsis.

Authors:  A Mirijello; A Tosoni; V Zaccone; M Impagnatiello; G Passaro; C V Vallone; A Cossari; G Ventura; G Gambassi; S De Cosmo; A Gasbarrini; G Addolorato; R Landolfi
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-05       Impact factor: 3.507

Review 2.  Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity.

Authors:  John S Adams; Martin Hewison
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-02

3.  Vitamin D: A simpler alternative to tocilizumab for trial in COVID-19?

Authors:  Morry Silberstein
Journal:  Med Hypotheses       Date:  2020-04-23       Impact factor: 1.538

4.  Does vitamin D status impact mortality from SARS-CoV-2 infection?

Authors:  Paul E Marik; Pierre Kory; Joseph Varon
Journal:  Med Drug Discov       Date:  2020-04-29

Review 5.  Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths.

Authors:  William B Grant; Henry Lahore; Sharon L McDonnell; Carole A Baggerly; Christine B French; Jennifer L Aliano; Harjit P Bhattoa
Journal:  Nutrients       Date:  2020-04-02       Impact factor: 5.717

6.  Serum 25-Hydroxyvitamin D and the risk of mortality in adult patients with Sepsis: a meta-analysis.

Authors:  Yuye Li; Shifang Ding
Journal:  BMC Infect Dis       Date:  2020-03-04       Impact factor: 3.090

Review 7.  The first, holistic immunological model of COVID-19: Implications for prevention, diagnosis, and public health measures.

Authors:  Paolo Maria Matricardi; Roberto Walter Dal Negro; Roberto Nisini
Journal:  Pediatr Allergy Immunol       Date:  2020-06-05       Impact factor: 5.464

  7 in total
  1 in total

1.  Vitamin D deficiency is associated with higher risks for SARS-CoV-2 infection and COVID-19 severity: a retrospective case-control study.

Authors:  Ariel Israel; Assi Cicurel; Ilan Feldhamer; Felicia Stern; Yosef Dror; Shmuel M Giveon; David Gillis; David Strich; Gil Lavie
Journal:  Intern Emerg Med       Date:  2022-01-09       Impact factor: 5.472

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.